Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Robinson

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Circulation|August 10, 2005
Letter regarding the article by Xue et al, "Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes"Richard B Robinson, Michael R Rosen, Peter R Brink, et al.
Pharmacological Research|April 20, 2006
I(f) and the biological pacemakerRichard B Robinson, Peter R Brink, Ira S Cohen, et al.
Pflugers Archiv : European Journal of Physiology|July 3, 2007
Modulation of cyclic nucleotide-regulated HCN channels by PIP(2) and receptors coupled to phospholipase CPhillip Pian, Annalisa Bucchi, Anthony Decostanzo, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 11, 2002
Block of the background K(+) channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factorAndrea Barbuti, Satoshi Ishii, Takao Shimizu, et al.
Nature Reviews. Cardiology|August 17, 2011
The road to biological pacingMichael R Rosen, Richard B Robinson, Peter R Brink, et al.
Medical & Biological Engineering & Computing|July 17, 2007
Biological pacemakers based on I(f)Michael R Rosen, Peter R Brink, Ira S Cohen, et al.
Discovery Medicine|August 14, 2010
Adult human stem cells as a platform for gene therapy: Fabricating a biological pacemakerMichael R Rosen, Peter R Brink, Ira S Cohen, et al.
Nature Clinical Practice. Cardiovascular Medicine|August 27, 2005
The why, what, how and when of biological pacemakersIra S Cohen, Peter R Brink, Richard B Robinson, et al.
Idrugs : the Investigational Drugs Journal|May 28, 2010
In vivo cellular delivery of siRNAPeter R Brink, Richard B Robinson, Michael R Rosen, et al.
Pflugers Archiv : European Journal of Physiology|August 13, 2008
Age-dependent differences in the inhibition of HCN2 current in rat ventricular myocytes by the tyrosine kinase inhibitor erbstatinYelena Kryukova, Vitalyi O Rybin, Jihong Qu, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Circulation|August 10, 2005
Letter regarding the article by Xue et al, "Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes"Richard B Robinson, Michael R Rosen, Peter R Brink, et al.
Pharmacological Research|April 20, 2006
I(f) and the biological pacemakerRichard B Robinson, Peter R Brink, Ira S Cohen, et al.
Pflugers Archiv : European Journal of Physiology|July 3, 2007
Modulation of cyclic nucleotide-regulated HCN channels by PIP(2) and receptors coupled to phospholipase CPhillip Pian, Annalisa Bucchi, Anthony Decostanzo, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 11, 2002
Block of the background K(+) channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factorAndrea Barbuti, Satoshi Ishii, Takao Shimizu, et al.
Nature Reviews. Cardiology|August 17, 2011
The road to biological pacingMichael R Rosen, Richard B Robinson, Peter R Brink, et al.
Medical & Biological Engineering & Computing|July 17, 2007
Biological pacemakers based on I(f)Michael R Rosen, Peter R Brink, Ira S Cohen, et al.
Discovery Medicine|August 14, 2010
Adult human stem cells as a platform for gene therapy: Fabricating a biological pacemakerMichael R Rosen, Peter R Brink, Ira S Cohen, et al.
Nature Clinical Practice. Cardiovascular Medicine|August 27, 2005
The why, what, how and when of biological pacemakersIra S Cohen, Peter R Brink, Richard B Robinson, et al.
Idrugs : the Investigational Drugs Journal|May 28, 2010
In vivo cellular delivery of siRNAPeter R Brink, Richard B Robinson, Michael R Rosen, et al.
Pflugers Archiv : European Journal of Physiology|August 13, 2008
Age-dependent differences in the inhibition of HCN2 current in rat ventricular myocytes by the tyrosine kinase inhibitor erbstatinYelena Kryukova, Vitalyi O Rybin, Jihong Qu, et al.
Pageof 9